We invest in medical device technologies that meaningfully improve clinical outcomes, procedural efficiency, and patient quality of life. Our focus is on scalable innovations with clear regulatory pathways, strong economic value propositions, and durable competitive advantages across surgical, interventional, and implantable device markets.